Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 402962Generated: October 30, 2026

Potassium Phosphate, Tribasic → acetic acid 2-(6-tert-butyl-8-fluoro-1-oxo-1H-phthalazin-2-yl)-6-{8-[5-(morpholine-4-carbonyl)-pyridin-2-ylamino]-quinolin-6-yl}-benzyl ester

https://huagongshe.com/reaction/402962

Reaction equation

Participants

RoleNameHCIDCharge
ReactantPotassium Phosphate, TribasicHCID 62657—
Reactant2-Dicyclohexylphosphino-2',4',6'-triisoprophylbiphenylHCID 11155794—
Reactant2-(6-(tert-Butyl)-8-fluoro-1-oxophthalazin-2(1H)-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl acetateHCID 59473769—
ReactantHCID 89612102HCID 89612102—
Catalyst(1E,4E)-1,5-diphenylpenta-1,4-dien-3-one; palladiumHCID 6505921—
Solvent1-ButanolHCID 263—
SolventWaterHCID 962—
Productacetic acid 2-(6-tert-butyl-8-fluoro-1-oxo-1H-phthalazin-2-yl)-6-{8-[5-(morpholine-4-carbonyl)-pyridin-2-ylamino]-quinolin-6-yl}-benzyl esterHCID 89612108—
Product6-tert-butyl-8-fluoro-2-(2-hydroxymethyl-3-{8-[5-(morpholine-4-carbonyl)-pyridin-2-ylamino]-quinolin-6-yl}-phenyl)-2H-phthalazin-1-oneHCID 89612127—

Reaction Conditions

Temperature110 °C

Reaction Steps

In a 25 ml round bottom flask containing 2-(6-tert-butyl-8-fluoro-1-oxophthalazin-2(1H)-yl)-6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl acetate (563 mg, 683 μmol, Eq: 1.4), (6-(6-chloroquinolin-8-ylamino)pyridin-3-yl)(morpholino)methanone (180 mg, 488 μmol, Eq: 1.00), X-PHOS (34.9 mg, 73.2 μmol) and potassium phosphate (228 mg, 1.07 mmol) was added BuOH (7 mL) and H2O (1.65 mL). The flask was evacuated and backfilled with argon before addition of Pd(dba)2 (19.6 mg, 34.2 μmol). The flask was evacuated and backfilled with argon again and heated at 110° C. for 2.5 hrs. LC/MS showed the presence of desired product as a mixture with 6-tert-butyl-8-fluoro-2-(2-hydroxymethyl-3-{8-[5-(morpholine-4-carbonyl)-pyridin-2-ylamino]-quinolin-6-yl}-phenyl)-2H-phthalazin-1-one. The reaction mixture was cooled to ambient temperature, diluted with 35 ml water and 35 ml EtOAc and shaken. The EtOAc phase was collected and washed with an equal volume of brine. The aqueous phase was back-extracted with 2×30 ml EtOAc. The combined organic extract was dried (MgSO4), and concentrated in vacuo. The crude product was purified by preparative thin layer chromatography (3 plates), eluting with 2% methanol/methylene chloride to provide the desired product (together with some 6-tert-butyl-8-fluoro-2-(2-hydroxymethyl-3-{8-[5-(morpholine-4-carbonyl)-pyridin-2-ylamino]-quinolin-6-yl}-phenyl)-2H-phthalazin-1-one) as a light brown foamy solid (310 mg).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS08742098B2
Source datasetuspto-grants-2014_06
ORD IDord-8f0edb2c4fb7404e952b96bc47ad8e75
Source noteuspto-grants-2014_06